PIL & Gene Solutions MoU
On April 25th, 2024, Premier Integrated Labs (PIL) and Gene Solutions came together for the signing of a memorandum of understanding. This partnership marks the collaboration of two leading entities, assured to transform cancer care through pioneering technology and innovative solutions.
PIL and Gene Solutions aim to redefine early cancer detection through Multi Cancer Early Detection (MCED) techniques and expand the scope of cancer care by implementing minimal residual disease monitoring. Leveraging Gene Solutions’ cutting-edge SPOT-MAS and K-TRACK tests, our combined efforts promise to reshape the healthcare landscape and improve patient outcomes.
This collaboration represents a union of expertise, innovation, and unwavering commitment to excellence. By combining PIL’s extensive diagnostic experience with Gene Solutions’ state-of-the-art technology, we aim to transform cancer care and make a meaningful difference in the lives of patients battling this disease.
Together, we aim to advance cancer care, striving for breakthroughs that make a tangible impact in the fight against cancer.
